Mechanisms that generate and maintain bone cancer pain
- PMID: 15283453
Mechanisms that generate and maintain bone cancer pain
Abstract
Although bone cancer pain can be severe and is relatively common, as it frequently arises from metastases from breast, prostate, and lung tumours, very little is known about the basic mechanisms that generate and maintain this chronic pain. To begin to define the mechanisms that give rise to bone cancer pain, we have developed mouse and rat models using the intramedullary injection and containment of tumour cells into the femur. These tumour cells induced bone remodelling as well as ongoing and movement evoked pain behaviours similar to that found in patients with bone cancer pain. In addition there is a significant reorganization of the spinal cord that received sensory input from the cancerous bone and this reorganization generated a neurochemical signature of bone cancer pain that is both dramatic and significantly different from that observed in mouse and rat models of chronic neuropathic or inflammatory pain. These models have provided insight into the mechanisms that drive cancer pain and have begun to allow the development of mechanism-based therapies. Together these advances should reduce tumour-induced pain and suffering and significantly improve the quality of life of cancer patients.
Similar articles
-
A mechanism-based understanding of bone cancer pain.Novartis Found Symp. 2004;261:194-214; discussion 214-9, 256-61. Novartis Found Symp. 2004. PMID: 15469052
-
Osteoprotegerin diminishes advanced bone cancer pain.Cancer Res. 2001 May 15;61(10):4038-47. Cancer Res. 2001. PMID: 11358823
-
Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.Cancer Res. 2002 Dec 15;62(24):7343-9. Cancer Res. 2002. PMID: 12499278
-
Similarities and differences in tumor growth, skeletal remodeling and pain in an osteolytic and osteoblastic model of bone cancer.Clin J Pain. 2006 Sep;22(7):587-600. doi: 10.1097/01.ajp.0000210902.67849.e6. Clin J Pain. 2006. PMID: 16926574 Review.
-
Pathophysiology of bone cancer pain.J Support Oncol. 2005 Jan-Feb;3(1):15-24. J Support Oncol. 2005. PMID: 15724942 Review.
Cited by
-
Molecular Mechanisms That Contribute to Bone Marrow Pain.Front Neurol. 2017 Sep 11;8:458. doi: 10.3389/fneur.2017.00458. eCollection 2017. Front Neurol. 2017. PMID: 28955292 Free PMC article. Review.
-
Animal models of cancer pain.Comp Med. 2008 Jun;58(3):220-33. Comp Med. 2008. PMID: 18589864 Free PMC article. Review.
-
Evaluating the Analgesic Effect of the GLS Inhibitor 6-Diazo-5-Oxo-L-Norleucine in Vivo.Pharm Pharmacol Int J. 2016;3(3):00055. doi: 10.15406/ppij.2015.03.00055. Epub 2016 Jan 8. Pharm Pharmacol Int J. 2016. PMID: 29888760 Free PMC article.
-
Effects of Src-kinase inhibition in cancer-induced bone pain.Mol Pain. 2016 Apr 18;12:1744806916643725. doi: 10.1177/1744806916643725. Print 2016. Mol Pain. 2016. PMID: 27094550 Free PMC article.
-
The Physiology of Bone Pain. How Much Do We Really Know?Front Physiol. 2016 Apr 26;7:157. doi: 10.3389/fphys.2016.00157. eCollection 2016. Front Physiol. 2016. PMID: 27199772 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical